Back Bay Life Science Report
Jonathan P. Gertler, MD and Peter Bak, PhD
Outreach Signals
Publishing Details
Contact & Outreach
About This Podcast
Podcasting 2.0 Features
Social Media
Explore Statistics
Recent Episodes
Evolving Oncology: The Expanding Landscape of Targeted Therapies and Investment
Examining the dynamic progress in targeted oncology, the episode delves into the shift from single-mutation therapies to broad pathway targeting, highlighting advances in EGFR, KRAS, and the MAPK…
ADC Revolution in Ovarian Cancer: Current Developments and Future Outlook
As ovarian cancer research enters a pivotal new era, Back Bay Life Science Advisors' Dr. Pete Bak is joined by Director Mavra Nasir and Consultant Trent Gordon for a deep dive into one of oncology's…
2025 Drug Approval Review
As the life sciences industry turns the page to 2026, Back Bay Life Science Advisors’ Dr. Pete Bak and Dr. Mavra Nasir take a detailed look back at FDA drug approvals in 2025, a year marked by…
A Capital Markets Outlook for 2025: 2024, A Year in Review
In this DNB//Back Bay Healthcare Capital Markets podcast episode, Jim Cirenza, Head of Fixed Income and Equities at DNB, Kristoffer Braaten, Director and Head of Equity Capital Markets at DNB, and…
The Optimism of Bispecific Antibodies
The topic of bispecific antibodies has been an area of interest in the pharma space for a long time now. The recent news of the notable late-stage data from Akeso and Summit’s PD-1/VEGF bispecific…
Dynamics in Healthcare Focused Markets
In this DNB//Back Bay Healthcare Capital Markets Episode, Vasilios Kofitsas, Partner and Managing Director at Back Bay Life Science Advisors speaks with Jim Cirenza and Kristoffer Braaten of DNB Bank…
From NASH to MASH: Current Market Dynamics in Hepatology
After a summer away from podcasting, Back Bay Life Science Advisors’ Dr. Pete Bak and Christian Thienel are back on the mic to discuss current market dynamics in liver disease with a focus on one of…
Key Considerations for a US Healthcare IPO
In this DNB//Back Bay Healthcare Capital Markets podcast episode, learn about the key considerations, mechanics and timelines of going public on a US exchange. Topics in this podcast include: An…
Drug Development in Obesity
Guests: Pete Bak and Christian Thienel Length: 27 minutes In this episode of The Life Science Report, Dr. Pete Bak and Back Bay Director, Christian Thienel catch up on the area attracting the most…
The Current Dynamics in Capital Markets
Welcome to another episode with the DNB//Back Bay Partnership for Healthcare.In this episode Jonathan Gertler, Back Bay CEO and Managing Partner, is once again joined by James Cirenza, Head of Fixed…
Vaccine Developments 2024: A Podcast Discussion on Latest Vaccine Technology and Ongoing Clinical Developments
Guests: Pete Bak and Christian Thienel Length: 37 minutes With the advent of COVID-19 in 2020 and 2021, we saw a tremendous amount of interest in not only COVID vaccines, but other companies riding…
Trends and Investment Activity in Radiopharmaceuticals and Psychedelics
A Podcast Discussion on the Trends and Investment Activity in Radiopharmaceuticals and PsychedelicsGuests: Pete Bak and Christian ThienelLength: 25 minutesHere at Back Bay we’ve seen a number of…
Vertex’s Exa-cel to Biogen and Sage’s Zurzuvae: Notable Product Approvals of 2023
As we move into 2024, Back Bay’s strategic advisors summarize key product approvals from three classes and indications over this past year, including the December CRISPR and Vertex approval of…
Monthly Roundup of News from Healthcare Development
In our latest podcast, Back Bay Life Science Advisors focused on the chronic and rare disease development of kidney disease. Recently, there have been some changes in treatment, some recent…
The Current and Future Landscape of Healthcare IPO Markets
With the DNB//Back Bay Partnership for HealthcareIn the current markets, Healthcare continues to rally as the second-largest industry behind technology in the stock market, and in the US markets…
The Heart of the Matter: Behind the Renewed Interest in Cardiovascular Disease
A conversation on the rising trends in the cardiology spaceCardiology has historically been a cornerstone of large pharmaceutical portfolios. The late 2000s and 2010s saw many pharmaceutical…
The Transactional Landscape Of ADCs: The Powerhouse of Antibody Drug Conjugates
In this episode, Dr. Peter Bak is joined by Trent Gordon and Dr. Mavra Nasir as they discuss their Bioprocess Online article published earlier this year, “The Transactional Landscape of ADCs: A…
Investing in Health Tech & Digital Medicine: Expert Talk with Mikaela Odlander & Edward Kliphuis
The world of health tech has changed dramatically since decades ago when physicians had to endure 11 keystrokes to prescribe a single aspirin. These days, AI-based radiology and AI-based pathology…
Contingencies for Biopharma, Medtech Deal Planning in a Down Market
For biopharma and medtech companies developing new treatments, capital for advancement and growth is invariably dependent on strategic preparation, differentiation, and persistence. Good preparation…
Gene Editing to Cross-Species Transplantation: The Most Compelling Healthcare Stories of 2022
In our first podcast episode of 2023, Back Bay’s strategic advisors summarize some of the most compelling healthcare development stories from 2022. From CRISPR and gene editing advancement to…
Frequently Asked Questions
Back Bay Life Science Report has published 35 episodes since June 2021, covering topics in Health & Fitness, Medicine.
Back Bay Life Science Report is currently highly active with new episodes monthly. Average episode length is 26m.
Sign up on Grep.FM to access contact details for Back Bay Life Science Report, including email and social media links.
Similar Podcasts
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
500 episodes
EMCrit FOAM Feed
Scott D. Weingart, MD FCCM
153 episodes
The Kevin Miller Podcast
Kevin Miller | YAP Media
1,683 episodes
Psychiatry & Psychotherapy Podcast
David Puder, M.D.
272 episodes
Behind The Knife: The Surgery Podcast
Behind The Knife: The Surgery Podcast
500 episodes
The Premed Years
Ryan Gray
640 episodes